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Abstract The aim of this study was to compare the utility of
BACTEC™ Mycosis-IC/F (Mycosis), BACTEC™ Plus
Aerobic/F (Aerobic), and BACTEC™ Plus Anaerobic/F
(Anaerobic) media in the detection of fungi from simulated
(obtained by the inoculation of tested media first with sterile
sheep’s blood and subsequently with one of 60 clinical yeast
isolates) and clinical blood samples, taken during routine
diagnostic examination in two hospitals. All tested strains
grew on Mycosis as well as Aerobic bottles, and the time to
detection obtained for Mycosis was significantly shorter
(p<0.05). The largest differences in the time to positivity
was found for Candida glabrata and Cryptococcus
neoformans, when Mycosis preceded Aerobic in 20–48 h
(mean 35.5 h) and 0.7–64 h (mean 24 h), respectively. On
the contrary, C. kruseiwere detected earlier in Aerobic media.
In clinical samples, the detection of C. glabrata was also
significantly faster in Mycosis than in Aerobic (29.22±
11.48 h compared to 86±40 h). The media complement each
other and, in 45 % of clinical examination sets, a single
positive medium was noted (25 % in Mycosis and 19 % in
Aerobic). The study proved that both Aerobic and Mycosis
media serve as the correct condition for the culture of fungi
and that they varied significantly in the detection time of
clinically important species. This result could suggest that
the simultaneous use of Aerobic as well as Mycosis media
may improve the time of diagnosis in many patients, especial-
ly those infected with C. glabrata or C. neoformans.
Introduction
A growing number of fungemia cases have been observed in
recent decades and Candida species have been placed as the
fourth most common microorganism isolated from blood
samples [1–3]. It is supposed that many cases of invasive
mycoses, including invasive candidosis, remain undiagnosed,
mostly because of the insufficient sensitivity of blood cultures,
which has been estimated as 50 % [3, 4]. In practices, many
patients have been successfully treated empirically. However,
because of the significant epidemiological changes observed
in recent decades, and the increase in the rate of infection due
to C. glabrata, C. krusei, or C. parapsilosis, which are fre-
quently resistant to azoles or echinocandins, such empirical
therapy may not necessarily hit causative pathogens. In order
to improve the early diagnosis of invasive fungal diseases,
several serological tests detecting fungal biomarkers (anti-
gens, DNA, or specific antibodies) have been developed, of
which only a few have gained acceptance for routine diagnos-
tics (glucan, mannan, anti-mannan) [3]. The results of each
serological test must be interpreted with caution due to the risk
of false results. The culture of fungi from normally sterile
tissue, including blood, remains an essential diagnostic test
for invasive mycoses. The isolation of causative pathogens,
followed by their subsequent identification and susceptibility
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testing, enables implementation of a proper therapy and has a
direct impact on the patient’s recovery.
According to the recommendations of the European Soci-
ety for Clinical Microbiology and Infectious Diseases Fungal
Infection Study Group (EFISG), blood from patients with
suspected candidemia should be cultured in aerobic and an-
aerobic media, to allow the growth of typical bacterial as well
as fungal pathogens. The EFISG emphasized that the culture
sensitivity and time to positivity may vary, depending on the
automatic blood culture systems and causative species [3].
One of the most widely used validated blood culture systems
is BACTEC 9240 (Becton Dickinson, USA). It was postulated
that this system can be less sensitive in the detection of some
fungi, depending on the medium used [3]. The addition of
BACTEC™Mycosis-IC/F (Mycosis), a selective medium for
fungi, to the standard set of aerobic and anaerobic bottles, e.g.,
BACTEC™ Plus Aerobic/F (Aerobic) and BACTEC™ Plus
Anaerobic/F (Anaerobic), is thought to be the best method to
enhance the sensitivity of fungal detection. However, due to
the low frequency of fungemia and costs enhancement, many
medical centers limit the practical use of such a specialized
medium. The presented study aimed to evaluate the utility of
the application of the Mycosis medium together with Aerobic
and Anaerobic BACTEC media, based on the analysis of
simulated as well as clinical blood samples.
Materials and methods
Strains
The study was performed on four Candida strains from the
American Type Culture Collection (C. albicansATCC 90028,
C. parapsilosis ATCC 90018, C. krusei ATCC 6258,
C. glabrata ATCC 90030) and 60 clinical blood isolates from
the laboratory collection of the Department of Microbiology,
Medical University of Wrocław, Wrocław, Poland (Table 1).
The strains were preserved in 40 % glycerol at −80 °C. The
24–48-h-old cultures on Sabouraud agar mediumwere used to
prepare a suspension of density 0.5 MF (in PBS), which was
subsequently diluted (10−2, 10−2) to obtain final concentra-
tions of 2–3 × 102 CFU/mL. The final number of cells was
tested by quantitative cultures on Sabouraud agar plates.
Preparation of simulated blood culture and processing
The blood culture bottles BACTEC™ Mycosis-IC/F (Myco-
sis), BACTEC™ Plus Aerobic/F (Aerobic), and BACTEC™
Plus Anaerobic/F (Anaerobic) were first inoculated aseptically
with sterile sheep’s blood (5 mL per bottle) and subsequently
with 50 μL of fungal suspension containing 10–20 fungal
cells (mean final density: 0.41 CFU/mL). The samples were
immediately placed in the compartment of the BACTEC 9240
and incubated until positivity (5 days for Aerobic and Anaer-
obic, and 14 days for Mycosis). During each experiment, the
strains were tested in triplicate. After incubation, positive as
well as negative bottles were subcultured on Sabouraud agar,
CHROMAgar Candida, and Columbia agar.
Statistical analysis of the results was performed with the
use of STATISTICA software. The positivity rate of a partic-
ular media was compared by Fisher’s exact test. For the
comparison of the time to detection (TTD), the Wilcoxon
matched-pairs signed-rank test and the t-test for differences
between means for independent variables were used. Values
of p<0.05 were considered as being statistically significant.
Analysis of the results of clinical blood samples testing
The results of blood cultures performed routinely in two
clinical hospitals were analyzed retrospectively. The first
Table 1 Time to detection (TTD) of simulated fungal blood cultures obtained in Mycosis and Aerobic media
Species (number of strains) Mycosis Aerobic Differencea Wilcoxon signed-rank test
Mean (h) (±SD) Range Mean (h) (±SD) Range Mean (h) (±SD)
C. albicans (14) 26.6 (5.6) 20–39 27.36 (4.6) 20.5–39.33 −0.75 (3.07) p=0.18
C. parapsilosis (12) 31.41 (3.41) 26.7–41 30.5 (4.21) 27.7–44.3 0.91 (2.39) p=0.06
C. glabrata (8) 21.36 (2.4) 19–25.5 56.9 (7.95) 44.2–70.3 −35.5 (7.46) p=0.0006
C. krusei (6) 21.07 (1.17) 18.5–23.7 19.09 (0.9) 17.5–21 1.97 (1.63) p=0.004
Candida spp.b (7) 41.03 (20.77) 19.2–75.8 36.57 (16.64) 18.2–69.2 4.46 (8.55) p=0.03
Cryptococcus neoformans (8) 55.24 (10.9) 42.5–77.3 78.27 (23.4) 47.8–113.3 −24 (24.1) p=0.0005
Othersc (5) 33.43 (11.6) 24.6–59.7 37.06 (18.6) 25.17–76 p=0.5
Total (60) 32.4 (13.9) 18–77.3 39.48 (21.8) 17.5–113.33 −7 (16.8) p=0.017
a Difference between TTD obtained in Mycosis and Aerobic media (Mycosis minus Aerobic)
bCandida spp. include C. guilliermondii (3), C. kefyr (2), C. spherica (1), and C. lipolytica (1)
c Others include Blastoschizomyces capitatus (3), Trichosporon asahii (1), and Exophiala spp. (1)
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hospital (Center I) analyzed a period of 26 months (January
2012 to February 2014), while the second (Center II) analyzed
a 12-month period (2013). The patients with a clinical indica-
tion for blood culture testing [e.g., fever with systemic inflam-
matory response syndrome (SIRS], organ and systemic infec-
tions, postoperative infections, urinary tract infections, pneu-
monia, meningitis, endocarditis, catheter-related infections,
etc.] were examined according to the standard protocols.
The analysis was limited to the examination sets cultured from
Aerobic, Anaerobic, and Mycosis bottles, taken at the same
time (one after another) and from the same place (venipunc-
ture or catheter). In both hospitals, inoculation of the media
with 8–10-mL blood aliquots was recommended; however,
the data regarding the real blood volume in particular samples
was not collected. The blood cultures were transported to the
laboratory in a thermo bag within 1–10 h and subsequently
incubated in the BACTEC 9240 compartment. Center I incu-
bated Aerobic media for up to 7 days, Anaerobic for up to
10 days, and Mycosis for up to 14 days. Center II applied 5
days (for Aerobic and Anaerobic) or 7 days (Mycosis) incu-
bation protocols. Cultured microorganisms were identified
with the use of the VITEK®2 Compact (bioMérieux) system
and tests.
Results
Bottles spiked with fungi
All the tested ATCC strains, as well as clinical isolates, grew
onMycosis as well as Aerobic bottles and no false-positive or
false-negative result was found in these media. The ATCC
strains were tested in three experiments (nine vials per strain).
The TTD of C. albicans ATCC 90028 (28.66±1.82 h in
Mycosis and 29.7±2.04 h in Aerobic), C. glabrata ATCC
90030 (21.66±0.817 h in Mycosis and 57.37±2.22 h in
Aerobic), and C. parapsilosis ATCC 90018 (31.16±0.577 h
in Mycosis and 30.58±0.82 h in Aerobic) were placed among
the range of TTD results obtained for clinical isolates of these
species (Table 1). In contrast, the detection of C. kruseiATCC
6258 was significantly delayed compared to clinical blood
isolates of C. krusei, which was noticeable in Mycosis
(24.46±1.44 h vs. 21.07±1.17 h for clinical isolates;
p<0.001; t-test for independent variables) as well as in Aero-
bic media (28.6±2.8 h vs. 19.09±0.9 h for clinical isolates;
p<0.0001; t-test for independent variables). A total number of
210Mycosis and 210 Aerobic bottles were used to test clinical
isolates (3–6 vials per single strain). The variability among the
TTD results obtained for a single strain in the same medium
was low (differences in the range 0–2.5 h). The most quickly
detected species were C. kefyr (2 isolates; 19.79±0.629 h in
Mycosis and 19±1.1 h in Aerobic) and C. krusei, which were
detected about 2 h earlier in Aerobic (19.09±0.9 h) than in
Mycosis media (21.07±1.17 h) (p<0.01; Wilcoxon test). In-
cubation of more than 1 day was required to detect isolates of
C. albicans, C. parapsilosis (Table 1), and C. guilliermondii
(3 isolates; 35.35±2.07 h in Mycosis and 33.35±1.12 h in
Aerobic), as well as Blastoschizomyces capitatus (3 isolates;
29.2±3.6 h in Mycosis and 28.47±4.56 h in Aerobic) and
T. asahii (1 isolate; 28.2±2.6 h in Mycosis and 27.8±3.2 h in
Aerobic). In the case ofC. glabrata, the detectionwas quick in
the Mycosis medium, in the range 19–25.5 h and about 35.5 h
longer in the Aerobic medium (range 44.2–70.3 h) (p<0.001).
Statistically significant differences in the TTD were also ob-
served for Cryptococcus neoformans (Mycosis overtook Aer-
obic in about 1–2 days), which represents the slowest growing
species (Table 1). With the exception of C. neoformans, the
highest TTD values were observed in the cultures of rare
fungal species, includingC. lipolytica (67.5±1.4 h inMycosis
and 67.42±2.47 h in Aerobic), C. spherica (74±2.5 h in
Mycosis and 50.4±2.9 h in Aerobic), and Exophiala sp.
58.9±1.06 h in Mycosis and 75.25±1.06 h in Aerobic. The
analysis of the detection time for the whole population of
blood isolates indicated statistically better results for Mycosis
media (mean difference 7 h, p<0.05).
In summary, the cultures on Mycosis media were positive
within 24 h for 23 (38.3 %) and within 48 h for 49 (81.6 %)
isolates. Positive Aerobic cultures were detected within 24 h
for 15 (25%) and within 48 h for 41 (68%) isolates. Forty-two
percent (25/60) of isolates were detected within 24 h on at
least one of these media.
In the case of the Anaerobic medium, the detection of
microbial growth by the BACTEC system was observed in
16 out of 180 vials (9 %), including 9/24 (37.5 %) bottles
inoculated with C. glabrata, 5/42 with C. albicans, 1/6 with
C. guilliermondii, and 1/3 with T. asahii. The TTD observed
forC. glabrata ranged between 21.5 and 28.8 h (mean 26.02±
3.34) and was lower than those obtained in Aerobic media
(p=0.000; t-test). After the subculture of negative vials on
solid media, fungal growth was found in 19/164 (11.58 %)
samples spiked with the following species: C. glabrata (12/
15), C. krusei (2/18), C. albicans (4/37), and Cryptococcus
neoformans (1/24).
Clinical blood samples positive for fungi
The analysis involved 51 sets of Aerobic, Mycosis, and An-
aerobic blood cultures taken at the same time and resulted in at
least one medium that was positive for fungi. With the excep-
tion of five examinations (from two patients) performed dur-
ing antifungal therapy with echinocandins, blood culture sets
were performed at the beginning of infection and before
introducing targeted antifungal therapy. Blood samples origi-
nated from 28 patients, seven of which tested positive for
concomitant bacterial infection. The causative fungal species
Eur J Clin Microbiol Infect Dis (2015) 34:161–167 163
were identified as C. glabrata (20 examination sets from 11
patients), C. parapsilosis (15/7), Saccharomyces cerevisiae
(11/7), C. albicans (3/2), and C. tropicalis (2/1). Thirty-five
out of 51 analyzed examination sets originated from 20 pa-
tients hospitalized in four departments (three surgical and one
intensive care) from Center I. Among yeast species isolated in
this hospital, C. glabrata (9 patients) and S. cerevisiae (7
patients) were dominant. Center II reported on 16 examination
sets from eight patients of a single intensive care unit (ICU).
Aerobic medium was positive in 13 and Mycosis in 11 exam-
ination sets, and the species isolated were C. parapsilosis (6
patients) and C. glabrata (2). Altogether, the highest yeast-
positivity ratios were shown by Mycosis (80.3 %) and Aero-
bic (72.5 %) media, while the positivity of Anaerobic was
significantly lower (25.49 %; p=0.0000) (Table 2). In 13
examination sets (25.4 %), fungi were grown exclusively on
Mycosis media, and in the next ten (19 %), the only positive
medium was Aerobic. No statistically significant differences
were observed in the positivity ratio related to the species
among Mycosis and Aerobic media. The Anaerobic medium
was significantly inferior to Mycosis and Aerobic in the
detection rate of C. glabrata and C. parapsilosis, but the
detection of S. cerevisiae (45 %) did not differ significantly
from Aerobic (65 %) and was much lower than Mycosis
(90 %; p=0.005).
The medium TTD of pure fungal cultures was lower on
Mycosis than on Aerobic media (50 h vs. 78 h, p=0.001),
especially for C. glabrata (28.76 h vs. 86 h) and S. cerevisiae
(53 h vs. 102 h) (Table 3). It was observed that, in the 12
examination sets, fungi (C. glabrata 7 strains, S. cerevisiae 4,
and C. albicans 1) were detected earlier on Mycosis than on
Aerobic media (differences of 15 h to 5 days), while Aerobic
detected C. tropicalis (1) and C. parapsilosis (6) faster than
Mycosis media (difference of 1–24 h). Due to the low number
of positive Anaerobic media, analysis of the TTD was per-
formed only for S. cerevisiae, which was detected significant-
ly faster on Anaerobic than on Aerobic media (p=0.004).
Mixed fungal-bacterial cultures were obtained in seven
Aerobic (C. glabrata and Enterococcus faecium 2,
C. parapsilosis andE. coli 2,C. parapsilosis andA. baumannii
1, S. cerevisiae and K. pneumoniae 1, S. cerevisiae and
S. epidermidis 1), six Anaerobic (C. glabrata and E. faecium
2,C. glabrata and E. coli 1,C. parapsilosis and E. coli 3), and
oneMycosis medium (C. parapsilosis and E. coli). The mixed
samples signaled positivity within 24 h (mean 11.35±8.65 h
on Aerobic and 13.14±3.9 h on Anaerobic). Among the vials
negative for fungi, bacterial growth was found in seven Aer-
obic (S. epidermidis 2, E. coli 2, S. aureus 1, S. haemolyticus
1, and Acinetobacter baumannii 1), six Anaerobic
(S. epidermidis 3, E. coli 2, S. aureus 1), and one Mycosis
medium (Acinetobacter baumannii).
Discussion
The data obtained in this study prove that both Aerobic and
Mycosis media serve as the right conditions for the culture of
pathogenic fungi and that the TTD in this media is related to
the species. The analysis of the performance of blood culture
systems and media in clinical settings represents the most
relevant validation test. Nevertheless, such an analysis is often
difficult, due to many factors, which could have an influence
on the recovery of fungi from the blood, e.g., fluctuations in
microbe density, presence of antibiotics and coexisting bacte-
rial infection, as well as the technical accuracy of the test
performance (blood volume, time of placement in the com-
partment, etc.). Most of these factors could easily be
Table 2 Positivity ratio of clinical blood samples cultured on Mycosis, Aerobic, and Anaerobic media




%b No. of vials
Y/Y+B/Ba
%b No. of vials
Y/Y+B/Ba
%b M/AE M/AN AE/AN
C. glabrata 20 15/0/0 75 12/2/1 70 1/3/2 15 1.0000 0.0020 0.0011
C. parapsilosis 15 11/1/1 80 10/3/1 86 2/3/0 33.3 1.0000 0.0253 0.0078
S. cerevisiae 11 10/0/0 90.9 5/2/4 63.63 5/0/3 45.5 0.3108 0.0052 0.6699
C. albicans 3 2/0/0 66 2/0/0 66 0/0/0 0
C. tropicalis 2 2/0/0 100 1/0/1 50 0/0/1 0
Total 51 40/1/1 80.39 30/7/7 72.5 8/5/6 25.49 0.4843 0.0000 0.0000
a Number of vials positive for: Y yeasts, Y+B yeasts and bacteria, B bacteria
b Percentage of vials positive for fungi, including mixed fungal-bacterial cultures
M/AE comparison between Mycosis and Aerobic in terms of positivity to yeasts
M/AN comparison between Mycosis and Anaerobic in terms of positivity to yeasts
AE/AN comparison between Aerobic and Anaerobic in terms of positivity to yeasts
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controlled via simulated, laboratory-prepared blood cultures,
which have been used by many investigators [5–11]. In the
presented study, both methods were applied. The culture of
fungi in the same conditions (the same amount of blood and
yeast inoculum) on three BACTEC media illustrated the ca-
pacity of the BACTEC system. The strains originated from
clinical blood samples and were collected in the mycological
laboratory of the Department of Microbiology of the Medical
University of Wrocław within a period of 7 years. The diver-
sity in the number of strains representing particular species
was connected to the frequency of infection. Unfortunately,
we did not routinely use Mycosis media and two other hospi-
tals were invited to study the clinical usefulness of BACTEC
media. The data provided were limited to examination sets
performed simultaneously on these three media; nevertheless,
they included almost all cases of occurring fungemia and
reflect specific epidemiological problems that arise, namely
the high proportion of infection due to Saccharomyces
cerevisiae in Center I and infection due to C. parapsilosis in
Center II.
It is well known that many fungal pathogens are character-
ized by slow multiplication and, for this reason, traditional
mycological practice has mandated at least 10–14 days incu-
bation time for blood cultures [12]. Therefore, it is important
that, in our study, all isolates were tested in simulated blood
cultures, but only one isolate of C. neoformans was detected
onMycosis as well as Aerobic media within 5 days—the time
usually accepted for bacterial blood cultures. In clinical sam-
ples, the longest incubation required to obtain positivity was
7 days, and it pertains to only two cases. These data support
recommendations of the EFISG (at least 5 days incubation) [3]
and the algorithm described recently by Bosshard, who pro-
posed 5–7 days of incubation of fungal blood cultures, except
for dimorphic fungi [12].
There are some discrepancies between reports about the
positivity ratio and false results obtained in simulated cultures
with BACTECmedia, especially BACTECAnaerobic, which
is a medium not designed for fungi. Some authors [8, 9], who
reported a positivity of Aerobic as high as 90–98 %, and
Anaerobic ranging between 10 and 15 %, found that almost
all vials which were signaled by the BACTEC system as
negative proved to be positive after terminal subculture. Con-
versely, according to the data collected by Klingspor et al. [6],
there was no growth observed after the subculture of negative
vials; thus, there was no false negativity. In the current study,
all isolates used to prepare simulated cultures were grown on
Aerobic and Mycosis, but the positivity ratio of Anaerobic
media was low (9 %). We observed that some negative An-
aerobic bottles (11 %) were positive in subcultures, of which a
high proportion was C. glabrata (12 out of 19; 63 %). Impor-
tantly, the number of fungal colonies growing after the sub-
culture of false-negative vials was low (1–10 CFU). It is clear
that the condition served in Anaerobic media poorly support
the growth of inoculated fungi, and that, in rare cases, despite
the negative signal of the BACTEC system, a limited fungal
cell load may be present. In the case of clinical blood samples,
the false-negative results are regarded rather seldom, but were
reported in some media of the BACTEC as well as
BacT/ALERT systems [13, 14]. Interestingly, in the
polymicrobial model of infection, detection of yeasts by An-
aerobic media was enhanced up to 79% [6]. This rule does not
apply to Aerobic media. A similar experiment performed by
Cateau et al. [11] with the media of the BacT/ALERT system
(bioMérieux), led to opposite results and conclusions; that is,
bacteria could hide the development of fungi. Also, Meyer
et al. [15], who analyzed the results of clinical blood cultures,
found that the detection of fungi from amixed fungal-bacterial
infection in an Aerobic medium was substantially reduced
compared to cases from monoinfection (27 % vs. 75 %).
The authors showed that, in such an infection, the use of
Mycosis, a medium inhibiting the growth of most bacteria,
significantly enhanced the probability of recovering fungi.
The data cited above once more argue for the necessity to
use different types of blood culture media in clinical practice.
The advantage of the application of specialized mycological
media is evident when analyzing the TTD of typical and rare
Table 3 Time to detection (TTD; in hours) of fungi in clinical blood samples cultured on Mycosis (M), Aerobic (AE), and Anaerobic (AN) media
(results for mixed fungal-bacterial cultures are not included)














C. glabrata 15 29.22±11.48 12 86±40 1 35.9 0.0000
C. parapsilosis 11 65±47.33 10 83±37 2 76±28.2 0.6290
S. cerevisiae 10 53.6±9.18 5 107.26±57.8 5 71.08±9.1 0.0108 0.004 0.204
C. albicans 2 24.74 2 39.29 0 0
C. tropicalis 2 20.63 1 15.63 0 0
Total 40 50±31.6 30 78.7±41.1 8 67.9±18.27 0.0012 0.1198 0.4769
a Student’s t-test for differences between means for independent variables
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etiological factors of fungemia. The most relevant difference
in the TTD pertains to C. glabrata, which, in our experimental
and clinical samples, similarly to other authors, was mostly
detected within 24 h in Mycosis and after 2–3 days in Aerobic
media [5–7]. It is also worthwhile to notice a complementary
role of Anaerobic media, whose ability to detectC. glabrata is
higher compared to other fungal species and the detection time
is reliably shorter than in Aerobic media (22–40 h, depending
on the study) [8, 9]. The exceptional results reported by Park
et al. [10] showed that the Aerobic medium spiked with
C. glabrata remained negative, whereas the Anaerobic medi-
um was 100 % positive. Recently, Cobos-Trigueros et al. [16]
analyzed the detection of C. glabrata on BACTEC Aerobic
and Anaerobic media (without Mycosis) in a large number of
candidemia cases. The authors found that the presence of
C. glabrata can be predicted on the basis of exclusive or
earlier detection of fungal growth in Anaerobic vials, but the
method was characterized by low sensitivity, in the range 31–
38 %. In our study, the usefulness of an Anaerobic medium in
the manner described above (i.e., Anaerobic will be positive
earlier than Aerobic) was supported by 1 out of 11 cases of
fungemia due to C. glabrata. Instead, the Mycosis medium
enables the early detection of C. glabrata in nine patients, in
four of which it was the only positive medium. C. glabrata
represents a frequent and emerging pathogen, less susceptible
or resistant to azoles and associated with high (29%)mortality
[3, 4, 17]. The distribution of C. glabrata depends on the
hospital department (hematology, ICU) and is also geograph-
ically related [3, 4, 17, 18]. In many European countries,
including Poland, C. glabrata is the second cause of
candidemia [18, 19]. The rapid detection and identification
of this pathogen is extremely important for introducing proper
therapy. It is clear that the use of Mycosis in patients with a
suspected C. glabrata infection should be especially recom-
mended. Recently, Tapia et al. [20] indicated that it is possible
to identify ICU patients at risk of developing C. glabrata
candidemia (less than 7 days in the hospital, abdominal sur-
gery, fluconazole use, or absence of renal failure). Due to the
medical and economical reasons that apply toMycosis togeth-
er with standard Aerobic and Anaerobic media, it may not
always be accepted. The finding of Tapia et al. [20] illustrates
that it is possible to narrow down the group of patients who are
at the highest risk and should be tested with specialized
mycological media.
The data obtained from simulated blood cultures presented
in this study and those reported by Fricker-Hidalgo et al. [5]
suggest that a very important indication for the application of
the Mycosis medium should also be cases with suspected
cryptococcosis.Cryptococcus neoformans is a species respon-
sible for meningitis, which is characterized by delayed growth
on typical media. The TTD of C. neoformans on Mycosis is
also late (55 h), but significantly faster than in Aerobic media
(78 h). Unfortunately, due to a low frequency of
cryptococcosis, this species has, so far, been poorly represent-
ed in the clinical studies evaluating blood culture media. The
comparison of Mycosis and Aerobic media performed previ-
ously by other authors [5] indicated statistically earlier detec-
tion inMycosis than in Aerobic media not only forC. glabrata
and C. neoformans, which was confirmed in this study, but
also for C. albicans, C. parapsilosis, or C. krusei. In the
presented study, the TTD of C. albicans and C. parapsilosis
on Mycosis were also shorter than on Aerobic media, but the
difference was not significant. In contrast, C. krusei were
detected 1.5–2 h quicker on Aerobic than on Mycosis media,
and this result was statistically significant. The clinical rele-
vance of such a small difference is doubtful, especially since
the TTD of C. krusei is relatively short in both media (19–
21 h). The above discrepancies suggest the presence of sig-
nificant intraspecies variability in the TTD existing in some
fungal species. The usefulness of BACTECmedia in a clinical
sitting was analyzed in several studies [4, 15, 21, 22]. The
published data are consistent in the sense that the positivity
ratio and TTD are better on Mycosis than on Aerobic media.
As an example, Chiarini et al. [21] found that Mycosis detect-
ed 77.4 %, Aerobic 71 %, and Anaerobic 8 % of fungal
infections. What is puzzling, however, is that, in our data as
well as in those described by Chiarini et al., a fourth of isolates
were detected only on Mycosis media. It may be, in part,
connected with the suppressive role of bacteria, which were
present in more than 10 % of fungi-negative Aerobic and
Anaerobic media. Another important factor affecting the re-
sults of blood cultures is the presence of antifungals. Accord-
ing to Köck et al. [7], Aerobic media showed better perfor-
mance than Mycosis in blood samples comprising
antimycotics, especially caspofungin or amphotericin B. Also,
in the study by Ericson et al. [22], the TTD on Mycosis was
significantly shorter than in BacT/Alert FA (bioMérieux) vials
in patients who did not receive antifungal therapy, whereas in
blood samples taken during therapy, the positivity of Mycosis
vials was reduced. Taking into account the above listed limi-
tations, it is understood that the usefulness ofMycosis may not
always be evident when analyzing a single medical ward and a
small patient population. The blood samples analyzed in this
study were taken mostly before introducing the initial therapy,
and are, thus, similar to those described by Ericson et al. [22].
We did not observe a difference in the positivity of Mycosis
and Aerobic but the TTD on Mycosis was significantly better
than on Aerobic media. It is worthwhile noting that Saccha-
romyces cerevisiae were detected even 2 days earlier on
Mycosis than on Aerobic media.
In summary, we conclude that the addition of a Mycosis
medium to the standard set of Aerobic and Anaerobic vials
improves the sensitivity of the detection of fungi and reduces
the detection time, which is dramatically high in infection due
to Candida glabrata, Cryptococcus neoformans, and Saccha-
romyces cereviasiae. The Mycosis and Aerobic media are
166 Eur J Clin Microbiol Infect Dis (2015) 34:161–167
characterized by different properties, the most important
among them being a better performance of Mycosis in mixed
polymicrobial infection and a better performance of Aerobic
in the presence of antifungals. Moreover, fungi showed nota-
ble inter- and intraspecies variability in the preference of
particular media, which, in practice, complements each other.
The simultaneous application of both Mycosis and Aerobic
media offers the possibility to detect a broader number of
isolates and improve the timing of the diagnosis.
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